Carcinogenesis Advance Access published online on April 28, 2005
Carcinogenesis, doi:10.1093/carcin/bgi108
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Division of Molecular Genetic Epidemiology, German Cancer Research Center, Heidelberg, Germany
* To whom correspondence should be addressed.
Received April 19, 2005
Accepted April 19, 2005
MOLECULAR EPIDEMIOLOGY AND CANCER PREVENTION
A bias in genotyping the ERBB2 (Her2) Ile655Val variant
2 Division of Molecular Genetic Epidemiology, German Cancer Research Center, Heidelberg, Germany; Department of Biosciences at Novum, Karolinska Institute, Huddinge, Sweden
Bernd Frank, E-mail: b.frank{at}dkfz.de
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
J. P. Breyer, M. E. Sanders, D. C. Airey, Q. Cai, B. L. Yaspan, P. A. Schuyler, Q. Dai, F. Boulos, M. G. Olivares, K. M. Bradley, et al. Heritable Variation of ERBB2 and Breast Cancer Risk Cancer Epidemiol. Biomarkers Prev., April 1, 2009; 18(4): 1252 - 1258. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. R. Benusiglio, C. Luccarini, O. Ajai, B. A.J. Ponder, and P. D. Pharoah Reply: a bias in genotyping of the ERBB2 (HER2) Ile655Val variant Carcinogenesis, December 1, 2005; 26(12): 2213 - 2213. [Full Text] [PDF] |
||||

